Prestige Consumer Healthcare Announces Upcoming Earnings Call

Prestige Consumer Healthcare Plans Earnings Release
Prestige Consumer Healthcare Inc. (NYSE: PBH) has made an important announcement regarding its fiscal 2026 second quarter earnings release. The company will share its results on Thursday, November 6, 2025, just before the market opens. Investors and analysts will have the opportunity to hear more about these results during a conference call scheduled for the same day at 8:30 a.m. ET.
How to Join the Conference Call
Anyone interested in participating in the live conference call can access it through the Investor Relations section of Prestige Consumer Healthcare’s website. For those who prefer to join via phone, registration is recommended to receive dial-in details and a unique access pin. It is advisable to connect at least ten minutes before the call starts to ensure a smooth experience.
Replay and Investor Relations Access
Following the live call, a replay will be made available for about a week on the company’s Investor Relations page. This will allow stakeholders who missed the call to catch up on the information shared regarding the company’s financial performance.
About Prestige Consumer Healthcare
Prestige Consumer Healthcare is dedicated to the marketing, sale, manufacturing, and distribution of consumer healthcare products across North America and other select international markets. The company has built a robust portfolio that includes well-known brands such as Monistat and Summer's Eve, which focus on women’s health. They also offer acclaimed products like BC and Goody's pain relievers, Clear Eyes and TheraTears for eye care, and many others targeting diverse health needs.
Expanding Reach and Innovation
Prestige Consumer Healthcare continues to expand its reach in the consumer health market through innovative products and strategic partnerships. With a commitment to quality and efficacy, the company aims to enhance the well-being of its customers. Their diverse offerings cater to various health needs, showcasing their adaptability and resilience in a competitive market.
Investor Contact Information
For further inquiries, stakeholders can reach out to the Investor Relations contact: Phil Terpolilli, CFA, at 914-524-6819 or email their inquiries to irinquiries@prestigebrands.com.
Frequently Asked Questions
What is the date for the fiscal 2026 second quarter earnings release?
The earnings release is scheduled for November 6, 2025.
How can I join the conference call?
Details on joining the conference call can be found on the company's Investor Relations page. Registration is recommended for phone access.
What products does Prestige Consumer Healthcare offer?
They offer a wide range of products, including Monistat, Summer's Eve, Dramamine, and many others focusing on different health concerns.
Who can I contact for more information?
You can contact Phil Terpolilli, CFA, at 914-524-6819 for investor inquiries.
Will there be a replay of the conference call?
Yes, a replay will be available on the Investor Relations page for about one week following the live call.
About The Author
Contact Lucas Young privately here. Or send an email with ATTN: Lucas Young as the subject to contact@investorshangout.com.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.